11 min listen
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
ratings:
Length:
13 minutes
Released:
Jul 31, 2023
Format:
Podcast episode
Description
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA. Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00119-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jul 31, 2023
Format:
Podcast episode
Titles in the series (43)
The Lancet Haematology: December 1, 2014 by The Lancet Haematology in conversation with